CSCO241206P61000
- 1.54
- +0.01+0.65%
Cisco Newsroom
Haisco Pharmaceutical Group (002653.SZ): has obtained the "Notice of Drug Clinical Trial Approval" for the innovative drug HSK46575 tablets.
On December 4th, Haisco Pharmaceutical Group (002653.SZ) announced that its subsidiary, Tibet Haisco Pharmaceutical Co., Ltd., recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. The tablet is named HSK46575 Tablet and is intended for the treatment of prostate cancer. HSK46575 Tablet is a self-developed oral, potent, and highly selective small molecule inhibitor designed for the treatment of prostate cancer. Preclinical research results indicate that this product has a clear target, precise efficacy, and good safety profile, making it a highly promising small molecule drug with significant potential for development. The benefits/risks of clinical application.
Will 2025 no longer be the era of the magnificent 7? Bank of America is bullish on this type of stocks...
①The chief strategist of Bank of America predicts that cyclical stocks (such as csi commodity equity index, construction, and infrastructure) will rise strongly, as investors will flow into the "old economy" sector; ②She believes that the USA economy is ready for a new spending cycle, and expects the s&p 500 index to rise to 6666 points next year.
Cisco Systems, Inc. (CSCO) Management Presents at 2024 UBS Global Technology and AI Conference (Transcript)
Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today
The Top 20 Technology Stocks Ranked by Quant
Cisco Systems To Present At 2024 UBS Global Technology And AI Conference; Webcast At 12:55 PM ET
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
SmarTrak.Ai Accelerates Growth With Strategic Funding and Major Contracts
Insider Sale: SVP & Chief Acctg Officer of $CSCO (CSCO) Sells 4,881 Shares
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
December Starts With a Mixed Market | Live Stock
A SoftBank Insider Describes His Wild Ride
Best Ranking and Performing Cybersecurity Stocks: FSLY, NET, FTNT
Is Cisco Systems Stock Underperforming the Dow?
Some May Be Optimistic About Cisco Systems' (NASDAQ:CSCO) Earnings
Can the US Share Market Keep Delivering? Spotlight on the 'Magnificent Seven'
Where to Look for Undervalued Technology Stocks
HGC Partners With Cisco to Put AI on Cybersecurity Services
Palantir: The Next Oracle? Expert Predicts A Monster Run To $100
The "bad news" for technology giants: Is Trump also anti-monopoly?
Reports indicate that Trump is considering appointing Slater as the head of the Justice Department's Antitrust Division, with analysts suggesting that this nomination means Trump will continue the tough enforcement stance advocated by the Biden administration.